Related Experiment Video
Updated: Mar 22, 2026
Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
Published on: November 30, 2012
Blood-Brain Barrier Breakdown Determines Differential Therapeutic Outcome in Genetically Diverse Forms of
Sylvaine Guerit1, Stefan Liebner1
1Institute of Neurology (Edinger-Institute), Johann Wolfgang Goethe-University Frankfurt Medical School, Heinrich-Hoffmann-Straße 7, 60528 Frankfurt, Germany.
Abstract:
Medulloblastoma driven by Wnt/β-catenin and Sonic hedgehog pathway mutations show favorable and poor patient survival upon treatment, respectively. In this Cancer Cell issue, Phoenix and colleagues (2016) report disruption of the blood-brain barrier by Wif1 specifically in Wnt-driven medulloblastoma, resulting in increased treatment response and survival in mouse models.
Insights
Researchers found that Wif1 disrupts the blood-brain barrier in Wnt-driven medulloblastoma, improving treatment outcomes and survival in mouse models. This discovery offers new therapeutic strategies for this brain tumor.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Medulloblastoma subtypes, including Wnt/β-catenin and Sonic hedgehog (SHH) driven, exhibit distinct clinical outcomes.
- The blood-brain barrier (BBB) presents a significant challenge in treating brain tumors like medulloblastoma.
Purpose of the Study:
- To investigate the role of Wnt inhibitory factor 1 (Wif1) in Wnt-driven medulloblastoma.
- To determine if Wif1 affects the blood-brain barrier and influences treatment response.
Main Methods:
- Utilized mouse models of Wnt-driven medulloblastoma.
- Assessed the impact of Wif1 on blood-brain barrier integrity.
- Evaluated treatment response and survival rates in the presence of Wif1 modulation.
Main Results:
- Wif1 was found to disrupt the blood-brain barrier specifically in Wnt-driven medulloblastoma.
- Disruption of the blood-brain barrier by Wif1 led to enhanced delivery of therapeutic agents.
- Increased treatment response and improved survival were observed in mouse models.
Conclusions:
- Wif1 plays a critical role in modulating blood-brain barrier permeability in Wnt-driven medulloblastoma.
- Targeting Wif1 to disrupt the BBB presents a potential therapeutic strategy to improve treatment efficacy for medulloblastoma.
- Further research into Wif1-mediated BBB disruption could lead to novel treatment approaches for pediatric brain tumors.
